Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTPN1 | P18031 | 1/20 | 0.54 |
| ▸ | DHODH | Q02127 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.45 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | DAO | P14920 | 2/20 | 0.42 |
| ▸ | LCK | P06239 | 1/20 | 0.42 |
| ▸ | FYN | P06241 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.39 |
| ▸ | LDHA | P00338 | 1/20 | 0.39 |
| ▸ | ACMSD | Q8TDX5 | 1/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | HMGB1 | P09429 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.38 |
| ▸ | CA4 | P22748 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28655905 | 0.97 | PTPN1 (0.52) | PTPN1DHODHALDH1A1ALOX15CYP1A2 | |
| SCHEMBL1498198 | 0.84 | PTPN1 (0.44) | PTPN1DHODHALDH1A1ALOX15CYP1A2 | |
| SCHEMBL351965 | 0.83 | — | — | |
| SCHEMBL8307343 | 0.81 | — | — | |
| SCHEMBL128958 | 0.81 | — | — | |
| SCHEMBL128959 | 0.81 | — | — | |
| SCHEMBL3662371 | 0.81 | — | — | |
| SCHEMBL2778839 | 0.81 | — | — | |
| SCHEMBL8306621 | 0.81 | — | — | |
| SCHEMBL17910882 | 0.81 | POLB (0.48) | PTPN1DHODHALDH1A1ALOX15CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 768 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2026-02-12 | — | — | US | claimed |
| EP-4680369-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GE Vernova Technology GmbH (CH) | 2026-01-21 | — | — | EP | claimed |
| WO-2025238576-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | Nuovo Pignone Tecnologie – S.r.l. (IT) | 2025-11-20 | — | — | WO | claimed |
| US-20250354659-A1 | SYSTEM AND METHOD FOR STORING LIQUIDS HAVING LOW LATENT HEAT OF VAPORIZATION | NUOVO PIGNONE TECNOLOGIE – S R L (IT) | 2025-11-20 | — | — | US | claimed |
| EP-4572884-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | General Electric Technology GmbH (CH) | 2025-06-25 | — | — | EP | claimed |
| EP-4556112-A2 | SORBENT COMPOSITIONS, SYSTEMS, AND METHODS | General Electric Technology GmbH (CH) | 2025-05-21 | — | — | EP | claimed |
| CN-119869460-A | Sorbent compositions, systems, and methods | 通用电气技术有限公司 | 2025-04-25 | — | — | CN | claimed |
| US-12263464-B2 | Method for in-situ synthesis of metal organic frameworks (MOFs), covalent organic frameworks (COFs) and zeolite imidazolate frameworks (ZIFs), and applications thereof | DESICCANT ROTORS INTERNATIONAL PRIVATE LIMITED (IN) | 2025-04-01 | — | — | US | claimed |
| WO-2024232872-A1 | SYSTEMS FOR CARBON DIOXIDE CAPTURE USING FUNCTIONALIZED SORBENTS AND WATER MANAGEMENT | GENERAL ELECTRIC TECHNOLOGY GMBH (CH) | 2024-11-14 | — | — | WO | claimed |
| US-20240276856-A1 | PREPARATION METHOD OF LIGHT-EMITTING DEVICE, LIGHT-EMITTING DEVICE AND LIGHT-EMITTING APPARATUS | Beijing Boe Technology Development Co., Ltd. (CN) | 2024-08-15 | — | — | US | claimed |
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | SANLUGEN PHARMATECH LTD. (CN) | 2012-04-12 | — | — | US | claimed |
| EP-2435498-A2 | GREEN SOLUBLE CONJUGATED POLYMERS WITH HIGH CHARGE CARRIER MOBILITIES | University of Florida Research Foundation, Inc. (US) | 2012-04-04 | — | — | EP | claimed |
| US-20120061630-A1 | GREEN SOLUBLE CONJUGATED POLYMERS WITH HIGH CHARGE CARRIER MOBILITIES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2012-03-15 | — | — | US | claimed |
| EP-2423215-A1 | PRODRUGS BASED ON GEMCITABINE STRUCTURE AS WELL AS SYNTHETIC METHOD AND APPLICATION THEREOF | Sanlugen Pharmatech Ltd. (CN) | 2012-02-29 | — | — | EP | claimed |
| EP-1578741-B1 | AROMATIC COMPOUNDS AS ANTI-INFLAMMATORY, IMMUNOMODULATORY AND ANTI-PROLIFERATORY AGENTS | 4SC AG (DE) | 2011-07-13 | — | — | EP | claimed |
| WO-2010138566-A2 | GREEN SOLUBLE CONJUGATED POLYMERS WITH HIGH CHARGE CARRIER MOBILITIES | UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2010-12-02 | — | — | WO | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| US-7365094-B2 | Compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | 4SC AG (DE) | 2008-04-29 | — | — | US | claimed |
| US-6316571-B1 | USED AS CATALYST FOR THE PREPARATION OF ALKYLENE GLYCOLS BY REACTING AN ALKYLENE OXIDE WITH WATER | SHELL OIL COMPANY | 2001-11-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120088908-A1 | Prodrugs Based on Gemcitabine Structure and Synthetic Methods and Applications Thereof | TYMP, DCTD, GLS2 | PTPN1 3836/4885DHODH 233/4885ALDH1A1 2629/4885 |
| US-20260042084-A1 | SORBENTS FUNCTIONALIZED WITH LIGANDS HAVING AN AMINOSILICONE FUNCTIONAL GROUP | SRMS, TYRO3, SELE | PTPN1 2776/4885DHODH 4332/4885ALDH1A1 3451/4885 |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | PTPN1 1478/4885DHODH 823/4885ALDH1A1 1901/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | PTPN1 1680/4885DHODH 1138/4885ALDH1A1 1510/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.